Sentence examples for genomic marker from inspiring English sources

This study is the first application that uses an entire genomic marker set as source of input information for genome-enabled prediction of milk traits in dairy cattle.

Our overall hypothesis was that a genomic marker(s) would identify responders to DrotAA and that a diagnostic kit could then be developed to help clinicians decide whom to treat with DrotAA.

The low-density array contains 281 57 60-mer oligonucleotide probes for detecting a wide range of specific genomic marker genes associated with antibiotic resistance, cell envelope structures, mobile genetic elements and pathogenicity.

Finally, we propose application of GRAMMAR-GC using the kinship matrix estimated through genomic marker data, instead of (possibly missing and/or incorrect) genealogy.

A genomic marker, 32P24_6, designed from the genomic sequence of a randomly selected subclone of 32P24 was also positive for 41P13 and 53I05, indicating that the OnubOR7b gene was located upstream of the OR gene cluster (Fig. 5).

Genome-wide association analysis was performed using the GenABEL package [46] in R using a three step GRAMMAR-CG approach, (Genome wide Association using Mixed Model and Regression - Genomic Control), with the extension of using the genomic kinship matrix estimated through genomic marker data, instead of the pedigree [39], [47].

Linkage analysis relies on evaluation of genomic markers to identify the region of the genome that segregates with the disease.

In order to test the feasibility of the genomic taxonomy in mycoplasmas, several genomic markers were analyzed in a collection of 46 genomes.

Marker-assisted breeding (usually called marker assisted selection) uses the genetic diversity found in crops or their wild relatives, combined with genomic data (genomic markers) to speed up what are otherwise essentially conventional breeding methods.

The next stage is to combine this vital sign data with other predictive data – such as genomic markers for conditions like breast cancer – to devise personalised treatment programmes tailored to a patient's risk profile.

The FDA halted the company's ability to inform new users about certain genomic markers related to their health in late 2013.